-
公开(公告)号:EP3950688A1
公开(公告)日:2022-02-09
申请号:EP20782749.4
申请日:2020-04-03
申请人: Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory , Medshine Discovery Inc.
发明人: WANG, Jiansong , FU, Zhifei , LUO, Zhibo , LUO, Miaorong , ZHANG, Yang , CAI, Yalei , ZHU, Wu , LI, Jian , CHEN, Shuhui , BAO, Yingxia , WANG, Wei , XIE, Zhoufan
IPC分类号: C07D471/10 , C07D401/14 , C07D403/14 , A61K31/506 , A61P35/00
摘要: Disclosed are a series of compounds with a nitrogen-containing spiro structure and an application thereof in the preparation of an RET kinase inhibitor. Specifically, disclosed is a compound as shown in formula (II) or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:EP4194455A1
公开(公告)日:2023-06-14
申请号:EP21874399.5
申请日:2021-09-26
申请人: Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. Baiyunshan Pharmaceutical General Factory
发明人: WANG, Jiansong , FU, Zhifei , LUO, Zhibo , LUO, Miaorong , ZHANG, Yang , LI, Jian , CHEN, Shuhui , BAO, Yingxia , WANG, Wei , XIE, Zhoufan
IPC分类号: C07D471/04 , A61K31/437 , A61P35/00
摘要: Provided are crystal forms of compounds represented by formula(II)-formula (VIII) and formula (I)-fbrmula (VIII-1), a preparation method therefor and an application of the compounds and crystal forms in the preparation of a drug for treating a related disease.
-
公开(公告)号:EP4089095A1
公开(公告)日:2022-11-16
申请号:EP21738457.7
申请日:2021-01-07
发明人: FU, Zhifei , LUO, Miaorong , ZHANG, Yang , LI, Jian , CHEN, Shuhui
IPC分类号: C07D495/04 , A61K31/4365 , A61K31/444 , A61P35/00
摘要: Disclosed is a deuterated thienopyridine compound. Specifically disclosed are a compound represented by formula (I) and a pharmaceutically acceptable salt thereof.
-
公开(公告)号:EP4458812A1
公开(公告)日:2024-11-06
申请号:EP22914793.9
申请日:2022-12-27
发明人: FU, Zhifei , LUO, Miaorong , YU, Chenxi , ZHOU, Kai , GAO, Na , ZHANG, Yang , LI, Jian , CHEN, Shuhui
IPC分类号: C07D237/32 , C07D403/10 , C07D487/00 , A61K31/502 , A61P35/00
摘要: Provided are a pyrazole-1(2H)-phthalazinone compound and an application thereof as a PRMTS. MTA complex inhibitor in the preparation of a drug for treating related diseases.
-
-
-